Esperion(ESPR) - 2024 Q2 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Conference Call August 12, 2024 8:00 AM ET Company Participants Alina Venezia - Director of Investor Relations Sheldon Koenig - President and Chief Executive Officer Ben Halladay - Chief Financial Officer Eric Warren - Chief Commercial Officer Betty Swartz - Chief Business Officer Conference Call Participants Dennis Ding - Jefferies Serge Belanger - Needham Cameron Bozdog - Bank of America Operator Ladies and gentlemen. Thank you for standing by. We ...